Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben-Horin

Showing results (141-150 of 362) with videos related to

Pageof 37
Sort By:
The Lancet. Gastroenterology & Hepatology|March 30, 2024
Ecogastroenterology: cultivating sustainable clinical excellence in an environmentally conscious landscapeKassem Sharif, Enrique Rodriguez de Santiago, Paula David, et al.
Inflammatory Bowel Diseases|April 28, 2016
Anti-infliximab Antibodies with Neutralizing Capacity in Patients with Inflammatory Bowel Disease: Distinct Clinical Implications Revealed by a Novel AssayRoni Weisshof, Bella Ungar, Alexandra Blatt, et al.
Annals of Gastroenterology|October 13, 2025
Accuracy of intestinal ultrasonography in the evaluation of patients with moderate-to-severe ulcerative colitis starting infliximab therapyAhmad Albshesh, Pesah Melnik, Arad Dotan, et al.
Journal of Clinical Medicine|November 18, 2020
Prediction of Recurrent Emergency Department Visits among Patients with Crohn's Disease: A Retrospective StudyHussein Mahajna, Yiftach Barash, Bella Ungar, et al.
BMC Gastroenterology|February 15, 2017
Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn's diseaseAdi Lahat, Uri Kopylov, Sandra Neuman, et al.
Therapeutic Advances in Gastroenterology|July 24, 2018
Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysisYuen Sau Tham, Diana E Yung, Shmuel Fay, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 18, 2026
Immunomodulatory therapies and emerging drug associations with microscopic colitis: A global pharmacovigilance analysisYaron Cohen, Andreas Münch, Asaf Levartovsky, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|November 19, 2015
Mapping Physiological Suitability Limits for Malaria in Africa Under Climate ChangeSadie J Ryan, Amy McNally, Leah R Johnson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 30, 2012
Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel diseaseShomron Ben-Horin, Matti Waterman, Uri Kopylov, et al.
Alimentary Pharmacology & Therapeutics|September 11, 2024
Differences in disease characteristics and treatment exposures between paediatric and adult-onset inflammatory bowel disease using a registry-based cohortMaya Granot, Uri Kopylov, Nurit Loberman-Nachum, et al.
Pageof 37

Showing results (141-150 of 362) with videos related to

Sort By:
Pageof 37
The Lancet. Gastroenterology & Hepatology|March 30, 2024
Ecogastroenterology: cultivating sustainable clinical excellence in an environmentally conscious landscapeKassem Sharif, Enrique Rodriguez de Santiago, Paula David, et al.
Inflammatory Bowel Diseases|April 28, 2016
Anti-infliximab Antibodies with Neutralizing Capacity in Patients with Inflammatory Bowel Disease: Distinct Clinical Implications Revealed by a Novel AssayRoni Weisshof, Bella Ungar, Alexandra Blatt, et al.
Annals of Gastroenterology|October 13, 2025
Accuracy of intestinal ultrasonography in the evaluation of patients with moderate-to-severe ulcerative colitis starting infliximab therapyAhmad Albshesh, Pesah Melnik, Arad Dotan, et al.
Journal of Clinical Medicine|November 18, 2020
Prediction of Recurrent Emergency Department Visits among Patients with Crohn's Disease: A Retrospective StudyHussein Mahajna, Yiftach Barash, Bella Ungar, et al.
BMC Gastroenterology|February 15, 2017
Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn's diseaseAdi Lahat, Uri Kopylov, Sandra Neuman, et al.
Therapeutic Advances in Gastroenterology|July 24, 2018
Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysisYuen Sau Tham, Diana E Yung, Shmuel Fay, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 18, 2026
Immunomodulatory therapies and emerging drug associations with microscopic colitis: A global pharmacovigilance analysisYaron Cohen, Andreas Münch, Asaf Levartovsky, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|November 19, 2015
Mapping Physiological Suitability Limits for Malaria in Africa Under Climate ChangeSadie J Ryan, Amy McNally, Leah R Johnson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 30, 2012
Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel diseaseShomron Ben-Horin, Matti Waterman, Uri Kopylov, et al.
Alimentary Pharmacology & Therapeutics|September 11, 2024
Differences in disease characteristics and treatment exposures between paediatric and adult-onset inflammatory bowel disease using a registry-based cohortMaya Granot, Uri Kopylov, Nurit Loberman-Nachum, et al.
Pageof 37